SCHEMBL9294238

SCHEMBL9294238

CCCC(O)CCCCCCn1c(=O)c2c(ncn2CCCCCCC(O)CCC)n(C)c1=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 6/20 0.62
LMNA P02545 3/20 0.62
CYP1A2 P05177 2/20 0.62
NFKB1 P19838 2/20 0.62
ACHE P22303 2/20 0.62
PMP22 Q01453 2/20 0.62
ESR1 P03372 1/20 0.62
MAPT P10636 1/20 0.62
BLM P54132 1/20 0.62
PDE4B Q07343 5/20 0.52
PDE4C Q08493 5/20 0.52
PDE4D Q08499 5/20 0.52
ADORA2A P29274 3/20 0.52
ADORA2B P29275 5/20 0.51
RXFP1 Q9HBX9 2/20 0.50
MAPK1 P28482 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
USP2 O75604 1/20 0.49
TNF P01375 1/20 0.49
TSHR P16473 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9293623 0.91 ADORA2B (0.63) PDE4ALMNAMAPTPDE4BPDE4C
SCHEMBL9294398 0.91 ADORA2B (0.63) PDE4ALMNAMAPTPDE4BPDE4C
SCHEMBL9293740 0.90 ADORA2B (0.62) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL8072448 0.90 ADORA2B (0.62) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL9294827 0.90 ADORA2B (0.62) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL9294512 0.89 PDE4A (0.56) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL10784265 0.89 PDE4A (0.60) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL11613504 0.89 PDE4A (0.62) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL11614003 0.89 PDE4A (0.62) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL11614554 0.89 PDE4A (0.62) PDE4ALMNACYP1A2NFKB1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5288721-A Substituted epoxyalkyl xanthines CELL THERAPEUTICS, INC. (US) 1994-02-22 US disclosed